Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,020 | 250 | 880 | 1,480 | 2,230 |
| Receivables | 3 | 30 | 10 | 0 | 0 |
| Other current assets | 37 | 130 | 50 | 60 | 10 |
| TOTAL | $2,060 | $410 | $940 | $1,540 | $2,240 |
| Non-Current Assets | |||||
| PPE Net | 1,010 | 1,000 | 1,000 | N/A | 1,000 |
| Investments And Advances | 150 | 150 | 150 | 150 | 0 |
| Other Non-Current Assets | 3,018 | 408 | 418 | 428 | 530 |
| TOTAL | $4,178 | $1,558 | $1,568 | $578 | $1,530 |
| Total Assets | $5,360 | $1,130 | $1,700 | $2,350 | $3,040 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 720 | 550 | 450 | 390 | 380 |
| Accrued Expenses | 4 | 9 | 10 | 30 | 0 |
| Other current liabilities | 150 | 80 | 80 | 0 | 0 |
| TOTAL | $930 | $720 | $650 | $530 | $470 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $3 | $8 | $20 | $50 |
| Total Liabilities | $930 | $730 | $660 | $550 | $520 |
| Shareholders' Equity | |||||
| Common Shares | 60 | 30 | 30 | 30 | 30 |
| Retained earnings | -25,540 | -24,830 | -23,940 | -23,140 | -22,380 |
| Other shareholders' equity | -10 | 0 | 0 | 0 | 0 |
| TOTAL | $4,430 | $400 | $1,040 | $1,790 | $2,510 |
| Total Liabilities And Equity | $5,360 | $1,130 | $1,700 | $2,340 | $3,030 |